Font Size: a A A
Keyword [Metastatic colorectal cancer]
Result: 121 - 138 | Page: 7 of 7
121. Study On The Dominant Population And Mechanism Of Qu-xie Capsule In Different Treatment Stages Of Metastatic Colorectal Cancer
122. Exploration Of Chemotherapy Regimens For Metastatic Colorectal Cancer
123. Analysis Of Factors Affecting The Prognosis Of Advanced Colorectal Cancer And Research On Dynamic Intervention Strategies Of Traditional Chinese Medicin
124. Study Of PRaG(Radiotherapy Combine PD-1 Inhibition And GM-CSF) Therapy In Mice Model Of Metastatic Colon Cancer
125. The Value Of 18F-FDG PET/CT In Predicting Perineural Invasion In Non-metastatic Colorectal Cancer
126. Efficacy And Safety Of Bevacizumab With Chemotherapy In Different Intervals As First Line Treatment For Metastatic Colorectal Cancer: A Comparative Real-word Study
127. Predictive Value Of Systemic Inflammatory Response Index On The Efficacy And Prognosis Of First-line Treatment For Patients With Metastatic Colorectal Cancer
128. To Study The Efficacy And Safety Of FOLFIRI Combined With/without Apatinib Mesylate In First-line Treatment Of Advanced Metastatic Colorectal Cancer Based On Propensity Score Matching Analysis
129. The Correlation Between Pan-Immune-Inflammation Value And Prognosis In Metastatic Colorectal Cancer Receiving First-Line Therapy
130. The Real World Study On Regorafenib As The Third-and Later-Line Treatment For Metastatic Colorectal Cancer
131. Comparison Of The Efficacy And Safety Of Fruquintinib And Regorafenib In The Treatment Of Metastatic Colorectal Cancer: A Real-world Study
132. Significance Of PIK3CA Mutation In Non-metastatic Colorectal Cancer
133. Multivariate Analysis Of The Prognosis Of Chemotherapy Combined With Bevacizumab For Metastatic Colorectal Cancer At Different Metastatic Sites
134. The Predictive Role Of Peripheral Blood NLR,PLR And SII On The Efficacy Of First-Line Cetuximab-Based Regimen In Patients With Ras Wild-Type Metastatic Colorectal Cancer
135. Prognostic Significance Of The Platelet-to-lymphocyte Ratio In Patients With Unresectable Metastatic Colorectal Cancer
136. A Systematic Review And Meta-analysis Of The Efficacy And Safety Of Anti-EGFR Antibody "Rechallenge" In Metastatic Colorectal Cancer
137. Optimization Of TCM Dynamic Intervention Treatment Strategy For Advanced Colorectal Cancer And Preliminary Exploration Of Health Economic
138. Real-world Study On The Population That Benefits From Guben Xiaoji Prescription Combined With Systemic Treatment For Metastatic Colorectal Cance
  <<First  <Prev  Next>  Last>>  Jump to